Clinical significance of revised microscopic positive resection margin status in ductal adenocarcinoma of pancreatic head

被引:9
作者
You, Yunghun [1 ]
Choi, Dong Wook [2 ]
Heo, Jin Seok [2 ]
Han, In Woong [2 ]
Choi, Seong Ho [3 ]
Jang, Kee-Taek [4 ]
Han, Sunjong [5 ]
Han, Sang Hyup [6 ]
机构
[1] Konkuk Univ, Sch Med, Konkuk Univ Choongju Hosp, Dept Surg, Chungju, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, 81 Irwon Ro, Seoul 06351, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Surg, Chang Won, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Surg, Seongnam, South Korea
[6] Yonsei Univ, Coll Med, Dept Hepatobiliary & Pancreat Surg, Seoul, South Korea
关键词
Pancreatic ductal carcinoma; Margins of excision; Pancreaticoduodenectomy; Survival; Recurrence; CANCER SURGERY; SURVIVAL; PANCREATICODUODENECTOMY; CLEARANCE; METAANALYSIS; RECURRENCE;
D O I
10.4174/astr.2019.96.1.19
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Recent studies have suggested microscopic positive resection margin should be revised according to the presence of tumor cells within 1mm of the margin surface in resected specimens of pancreatic cancer. However, the clinical meaning of this revised margin status for R1 resection margin was not fully clarified. Methods: From July 2012 to December 2014, the medical records of 194 consecutive patients who underwent pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head were analyzed retrospectively. They were divided into 3 groups on margin status; revised microscopic negative margin (rRO) - tumor exists more than 1 mm from surgical margin, revised microscopic positive margin (rR1) - tumor present within less than 1 mm from surgical margin, classic microscopic positive margin (cR1) - tumor is exposed to surgical margin. Results: There were 76 rR0 (39,2%), 100 rR1 (51.5%), and 18 cR1 (9.3%), There was significant difference in disease-free survival rates between cR1 vs. rR1 (8.4 months vs. 24.0 months, P = 0.013). Margin status correlated with local recurrence rate (17.1% in rR0, 26.0% in rR1, and 44.4% in cR1, P = 0.048). There is significant difference in recurrence at tumor bed (11.8% in rR0 vs. 23.0 in rR1, P = 0.050). Of rR1, adjuvant treatment was found to be an independent risk factor for local recurrence (hazard ratio, 0.297; 95% confidence interval, 0.127-0.693, P = 0.005). Conclusion: Revised R1 resection margin (rR1) affects recurrence at the tumor bed. Adjuvant treatment significantly reduced local recurrence of rR1. Accordingly, adjuvant chemoradiation for rR1 group should be taken into account.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 50 条
  • [21] Clinical Significance of Neoadjuvant Chemotherapy With Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma
    Suzuki, Takashi
    Mori, Shozo
    Shimizu, Takayuki
    Tago, Kazuma
    Harada, Nobuhiro
    Park, Kyung-Hwa
    Sakuraoka, Yuhki
    Shiraki, Takayuki
    Iso, Yukihiro
    Aoki, Taku
    Kubota, Keiichi
    IN VIVO, 2019, 33 (06): : 2027 - 2035
  • [22] Preoperative Biopsy Is Not Associated With Adverse Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Upfront Resection
    Servin-Rojas, Maximiliano
    Bolm, Louisa
    Lillemoe, Keith D.
    Fong, Zhi Ven
    Narayan, Raja R.
    Castillo, Carlos Fernandez-Del
    Qadan, Motaz
    JOURNAL OF SURGICAL RESEARCH, 2025, 307 : 33 - 41
  • [23] Redefining resection margin status in pancreatic cancer
    Verbeke, Caroline S.
    Menon, Krishna V.
    HPB, 2009, 11 (04) : 282 - 289
  • [24] Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma
    Crippa, Stefano
    Pergolini, Ilaria
    Javed, Ammar A.
    Honselmann, Kim C.
    Weiss, Matthew J.
    Di Salvo, Francesca
    Burkhart, Richard
    Zamboni, Giuseppe
    Belfiori, Giulio
    Ferrone, Cristina R.
    Rubini, Corrado
    Yu, Jun
    Gasparini, Giulia
    Qadan, Motaz
    He, Jin
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    Wolfgang, Christopher L.
    Falconi, Massimo
    ANNALS OF SURGERY, 2022, 276 (02) : 378 - 385
  • [25] Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy
    Schmocker, Ryan K.
    Delitto, Daniel
    Wright, Michael J.
    Ding, Ding
    Cameron, John L.
    Lafaro, Kelly J.
    Burns, William R.
    Wolfgang, Christopher L.
    Burkhart, Richard A.
    He, Jin
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (04) : 405 - 413
  • [26] Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions
    Pine, J. K.
    Haugk, B.
    Robinson, S. M.
    Darne, A.
    Wilson, C.
    Sen, G.
    French, J. J.
    White, S. A.
    Manas, D. M.
    Charnley, R. M.
    PANCREATOLOGY, 2020, 20 (03) : 537 - 544
  • [27] Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head?
    Janot, M. S.
    Kersting, S.
    Belyaev, O.
    Matuschek, A.
    Chromik, A. M.
    Suelberg, D.
    Uhl, W.
    Tannapfel, A.
    Bergmann, U.
    LANGENBECKS ARCHIVES OF SURGERY, 2012, 397 (06) : 917 - 925
  • [28] In the Era of the Leeds Protocol: A Systematic Review and A Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma Patients
    Kurlinkus, B.
    Ahola, R.
    Zwart, E.
    Halimi, A.
    Yilmaz, B. S.
    Ceyhan, G. O.
    Laukkarinen, J.
    SCANDINAVIAN JOURNAL OF SURGERY, 2020, 109 (01) : 11 - 17
  • [29] <bold>Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma</bold>
    Markov, Pavel
    Satoi, Sohei
    Kon, Masanori
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2016, 23 (09) : 523 - 532
  • [30] Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma
    Lu, Xiong-Xiong
    Zhang, Shu-Min
    Fang, Yuan
    Wang, Zheng-Ting
    Xie, Jun-Jie
    Zhan, Qian
    Deng, Xia-Xing
    Chen, Hao
    Jin, Jia-Bin
    Peng, Cheng-Hong
    Li, Hong-Wei
    Shen, Bai-Yong
    TUMOR BIOLOGY, 2013, 34 (06) : 3339 - 3343